Aardvark Therapeutics, Inc.
AARD
$11.75
-$0.064-0.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 105.34% | -10.56% | 0.00% | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 949.04% | 84.71% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | 17.65% | -- | ||
| Total Current Assets | 108.47% | -10.32% | -- | ||
|
|
|||||
| Total Current Assets | 108.47% | -10.32% | -- | ||
| Net Property, Plant & Equipment | -14.56% | -12.60% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -30.06% | 1,035.78% | -- | ||
| Total Assets | 102.59% | -7.44% | -- | ||
|
|
|||||
| Total Accounts Payable | 11.23% | 245.05% | -- | ||
| Total Accrued Expenses | 32.26% | 41.16% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 15.38% | 4.64% | -- | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | 21.29% | 88.63% | -- | ||
|
|
|||||
| Total Current Liabilities | 21.29% | 88.63% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -23.81% | -19.08% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -7.69% | -- | -- | ||
| Total Liabilities | 17.46% | 70.86% | -- | ||
|
|
|||||
| Common Stock & APIC | 5,825.14% | 9.19% | -- | ||
| Retained Earnings | -15.96% | -17.72% | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 375.77% | -18.34% | 0.00% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 0.00% | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 0.00% | 0.00% | ||
|
|
|||||
| Total Common Equity | 375.77% | -18.34% | 0.00% | ||
| Total Preferred Equity | -- | 0.00% | 0.00% | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 108.96% | -10.51% | 0.00% | ||
|
|
|||||